MCL1 and breast carcinoma: Both loss-of-function mutations and promoter hypermethylation of the E3 ubiquitin ligase FBW7 have been identified in breast tumors suggesting that the extent of MCL-1 protein upregulation in breast cancer may be as yet underappreciated [82,83].